Chris Dall | News Reporter | CIDRAP NewsJun 03, 2020Lancet editors issue a statement acknowledging the criticism of a recent study.
Controversy over data in hydroxychloroquine COVID-19 study grows
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows